Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $375.7600 (0.82%) ($375.7600 - $375.7600) on Fri. Dec. 20, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.64% (three month average) | RSI | 62 | Latest Price | $375.7600(0.82%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | REGN advances 0.5% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(58%) XLV(47%) IVW(41%) IWF(40%) QQQ(40%) | Factors Impacting REGN price | REGN will decline at least -0.82% in a week (0% probabilities). VIXM(-24%) VXX(-10%) TLT(-5%) TIP(-1%) IGOV(1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.82% (StdDev 1.64%) | Hourly BBV | 1.7 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $373.03(0.73%) | 10 Day Moving Average | $372.13(0.98%) | 20 Day Moving Average | $370.07(1.54%) | To recent high | -0.2% | To recent low | 37.5% | Market Cap | $39.841b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |